Noboru Takata

1.8k total citations
76 papers, 1.1k citations indexed

About

Noboru Takata is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Noboru Takata has authored 76 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 22 papers in Hepatology and 12 papers in Epidemiology. Recurrent topics in Noboru Takata's work include Organ Transplantation Techniques and Outcomes (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Liver physiology and pathology (9 papers). Noboru Takata is often cited by papers focused on Organ Transplantation Techniques and Outcomes (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Liver physiology and pathology (9 papers). Noboru Takata collaborates with scholars based in Japan, United States and Nigeria. Noboru Takata's co-authors include Takehisa Yairi, Naoya Takeishi, Naoki Nishimura, Kazunori Harada, Kuniaki Arai, Tatsuya Yamashita, Shouzaburou Uemura, Eishiro Mizukoshi, Kazuo Awai and Takeshi Nakaura and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Diabetes Care.

In The Last Decade

Noboru Takata

68 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noboru Takata Japan 17 224 219 163 145 128 76 1.1k
Lehn K. Weaver United States 16 133 0.6× 213 1.0× 44 0.3× 209 1.4× 43 0.3× 29 2.3k
Kentaro Yoshioka Japan 25 127 0.6× 1.3k 5.9× 33 0.2× 30 0.2× 1.4k 10.9× 97 2.2k
Peter Hufnagl Germany 30 92 0.4× 325 1.5× 7 0.0× 346 2.4× 53 0.4× 135 3.1k
Jeong Mi Park United States 24 74 0.3× 302 1.4× 10 0.1× 549 3.8× 69 0.5× 145 2.4k
Nicolas Jay France 16 35 0.2× 141 0.6× 15 0.1× 121 0.8× 18 0.1× 49 1.1k
M. Wiesel Germany 25 80 0.4× 319 1.5× 7 0.0× 656 4.5× 90 0.7× 90 2.5k
Shiquan Wu China 12 85 0.4× 75 0.3× 83 0.5× 19 0.1× 7 0.1× 34 681
Shu‐Fu Lin Taiwan 23 48 0.2× 260 1.2× 12 0.1× 127 0.9× 121 0.9× 53 1.3k
Huaizhong Hu United States 20 44 0.2× 213 1.0× 10 0.1× 466 3.2× 75 0.6× 53 1.7k
Masahiro Ito Japan 25 90 0.4× 151 0.7× 8 0.0× 839 5.8× 303 2.4× 126 2.1k

Countries citing papers authored by Noboru Takata

Since Specialization
Citations

This map shows the geographic impact of Noboru Takata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noboru Takata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noboru Takata more than expected).

Fields of papers citing papers by Noboru Takata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noboru Takata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noboru Takata. The network helps show where Noboru Takata may publish in the future.

Co-authorship network of co-authors of Noboru Takata

This figure shows the co-authorship network connecting the top 25 collaborators of Noboru Takata. A scholar is included among the top collaborators of Noboru Takata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noboru Takata. Noboru Takata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okada, Hikari, Alessandro Nasti, Yoshio Sakai, et al.. (2025). Evaluation of Long-Read RNA Sequencing Procedures for Novel Isoform Identification and Quantification in Human Whole Blood. Genes. 16(9). 1075–1075.
2.
Terashima, Takeshi, Makoto Yamamoto, Tadashi Toyama, et al.. (2025). The efficacy and safety of adding hepatic arterial infusion chemotherapy using cisplatin to lenvatinib for advanced hepatocellular carcinoma. Hepatology Research. 55(7). 1026–1037.
3.
Terashima, Takeshi, Tatsuya Yamashita, Kuniaki Arai, et al.. (2024). Comprehensive genomic profiling for advanced hepatocellular carcinoma in clinical practice. Hepatology International. 19(1). 212–221. 3 indexed citations
4.
Sugiyama, Aya, Teruhisa Fujii, Fumie Sasaki, et al.. (2021). Outcomes of Patients Who Undergo Transfusion of Fresh Frozen Plasma: A Prospective, Observational, Multicentre Cohort Study in Hiroshima, Japan. Journal of Blood Medicine. Volume 12. 965–973. 5 indexed citations
5.
Terashima, Takeshi, Tatsuya Yamashita, Noboru Takata, et al.. (2020). Safety and efficacy of sorafenib followed by regorafenib or lenvatinib in patients with hepatocellular carcinoma. Hepatology Research. 51(2). 190–200. 8 indexed citations
6.
Takeshita, Yumie, Takehiro Kanamori, Takeo Tanaka, et al.. (2020). Study Protocol for Pleiotropic Effects and Safety of Sodium–Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease. Diabetes Therapy. 11(2). 549–560. 6 indexed citations
7.
Terashima, Takeshi, Tatsuya Yamashita, Noboru Takata, et al.. (2015). Post‐progression survival and progression‐free survival in patients with advanced hepatocellular carcinoma treated by sorafenib. Hepatology Research. 46(7). 650–656. 43 indexed citations
8.
Arima, Kota, et al.. (2015). Acute gastric volvulus in a patient with trisomy 21. Surgical Case Reports. 1(1). 5–5. 3 indexed citations
9.
Kodama, Ken, et al.. (2012). A PROPOSED STANDARD CURRICULUM IN TRANSFUSION MEDICINE FOR JAPANESE MEDICAL SCHOOLS. Japanese Journal of Transfusion and Cell Therapy. 58(5). 720–725. 2 indexed citations
10.
Yairi, Takehisa, et al.. (2011). Spacecraft Telemetry Monitoring Method Based on Dimensionality Reduction and Clustering. JOURNAL OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES. 59(691). 197–205. 10 indexed citations
11.
Yairi, Takehisa, et al.. (2011). Data monitoring of spacecraft using mixture probabilistic principal component analysis and hidden Semi-Markov models. 141–144. 4 indexed citations
12.
Yairi, Takehisa, Yoshinobu Kawahara, & Noboru Takata. (2010). Spacecraft telemetry data monitoring by dimensionality reduction techniques. Society of Instrument and Control Engineers of Japan. 1230–1234. 12 indexed citations
13.
Shirahata, Akira, Toshiaki Oka, Katsuyuki Fukutake, et al.. (2006). Long-term safety and efficacy of recombinant activated factor VII (NovoSeven) in haemophilia patients with inhibitors: interim post marketing study analysis of 5 patient exposure years. Japanese Journal of Thrombosis and Hemostasis. 17(3). 331–344. 3 indexed citations
14.
Taniguchi, K., et al.. (2005). . Journal of the Japan Society of Blood Transfusion. 51(5). 543–544. 1 indexed citations
15.
Taniguchi, K., et al.. (2002). Human neutrophil antigen‐2a expression on neutrophils from healthy adults in western Japan. Transfusion. 42(5). 651–657. 23 indexed citations
16.
Fujii, Teruhisa, et al.. (2001). . Journal of the Japan Society of Blood Transfusion. 47(5). 794–795.
17.
Fujii, Teruhisa, Yasuhiro Kato, Noboru Takata, & A. Kimura. (2001). Change in Plasma Viral Load, and Viral DNA and mRNA Burdens, in Peripheral Blood Mononuclear Cells from Patients Infected with HIV-1. Journal of Infection. 42(1). 20–26. 1 indexed citations
18.
Taniguchi, K., et al.. (1999). Development of A Novel Monoclonal Antibody, TAG2, to The Neutrophil-Specific Antigen NA2.. Journal of the Japan Society of Blood Transfusion. 45(5). 629–631. 1 indexed citations
19.
Taniguchi, K., et al.. (1998). Production of a Monoclonal Antibody, TAG1, to the Neutrophil-Specific Antigen NA1.. Journal of the Japan Society of Blood Transfusion. 44(3). 309–316. 1 indexed citations
20.
Takata, Noboru, et al.. (1989). In-orbit performance of CS-3A spacecraft GaAs solar array. 823–828. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026